Transatlantique Private Wealth LLC Tyme Technologies, Inc. Transaction History

Transatlantique Private Wealth LLC

  • $243 Million
  • Q2 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022
BUY
$0.23 - $0.35 $3,680 - $5,600
16,000 New
16,000 $4,000

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Transatlantique Private Wealth LLC Portfolio

Follow Transatlantique Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Transatlantique Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Transatlantique Private Wealth LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email